Skip to main content

Advertisement

Table 3 Anti-CCP concentrations in studied groups

From: Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis

  PsA (n = 40) Psoriasis without arthritis (n = 40) RA (n = 40) Healthy Controls (n = 40) P-value
Mean ± SD 8.25 ± 11.6 2.435 ± 1.3 28.63 ± 11.75 2.68 ± 1.3 < 0.001
Median 3.8 2.5 32 1.8  
  1. PsA: psoriatic arthritis, RA: rheumatoid arthritis